Coty Inc. (COTY)
Coty Inc., together with its subsidiaries, manufactures, markets, distributes, and sells branded beauty products in the United States and internationally. It operates through two segments: Prestige and Consumer Beauty. The company provides fragrances, color cosmetics, and skin and body care products. It offers prestige products through prestige retailers, including perfumeries, department stores, e-retailers, direct-to-consumer websites, and duty-free shops under Burberry, Calvin Klein, Chloe, Davidoff, Escada, Etro, Gucci, Hugo Boss, Infiniment Coty Paris, Jil Sander, Joop!, Kylie Cosmetics by Kylie Jenner, Lancaster, Marc Jacobs, Orveda, philosophy, and Tiffany & Co. brands. The company provides beauty products through hypermarkets, supermarkets, drug stores, pharmacies, mid-tier department stores, traditional food and drug retailers, and e-commerce retailers under the Adidas, David Beckham, Bozzano, Bourjois, Bruno Banani, CoverGirl, Jovan, LeGer by Lena Gercke, Max Factor, Mexx, Monange, Nautica, Paixao, Rimmel, Risque, Vera Wang, and Sally Hansen brands. It also sells its products through third-party distributors. Coty Inc. was founded in 1904 and is headquartered in New York, New York. Coty Inc. operates as a subsidiary of JAB Beauty B.V.
- Symbol
- COTY
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Market cap
- $2.32B
- 52 week range
- 1.82 - 4.47
Valuation
- Share price
- $2.64 (close of 2026-09-23)
- P/E (TTM)
- -3.77x
- Price to book
- 0.74x
- Price to free cash flow
- 6.68x
- Enterprise value
- $5.44B
- Book value per share
- $3.59
Price performance
| Period | Change |
|---|
| 1 day | +5.18% |
| 5 days | -0.38% |
| 1 month | -3.65% |
| 3 months | +34.69% |
| 6 months | +23.36% |
| Year to date | -14.29% |
| 1 year | -34.00% |
| 3 years | -77.76% |
| 5 years | -68.00% |
| 10 years | -88.71% |
| All time | -84.79% |
Profitability and growth
- Return on equity
- -19.13%
- Return on invested capital
- -0.98%
- Return on assets
- -5.93%
- Return on capital employed
- -1.06%
- Gross margin
- 62.89%
- Net margin
- -10.42%
- EBITDA margin
- 6.90%
- Revenue growth
- -1.46%
- Net income growth
- -64.39%
- Free cash flow growth
- 25.43%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 14.98%
- Current ratio
- 0.75x
- Net debt to EBITDA
- 43.21x
Latest reported year
- Period end
- 2026-06-30
- Fiscal year
- 2026
- Revenue
- $5.81B
- Cost of revenue
- $2.15B
- Gross profit
- $3.65B
- EBITDA
- $400.70M
- Net income
- $-604.80M
- Earnings per share
- $-0.70
- Research and development
- $121.20M
- Shares outstanding
- 877.40M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2026-06-30 | $5.81B | $3.65B | $-604.80M | $-0.70 |
| 2025-06-30 | $5.89B | $3.82B | $-367.90M | $-0.44 |
| 2024-06-30 | $6.12B | $3.94B | $89.40M | $0.09 |
| 2023-06-30 | $5.55B | $3.55B | $508.20M | $0.58 |
| 2022-06-30 | $5.30B | $3.37B | $259.50M | $0.08 |
| 2021-06-30 | $4.63B | $2.77B | $-201.30M | $-0.40 |
| 2020-06-30 | $4.72B | $2.73B | $-1.01B | $-1.33 |
| 2019-06-30 | $6.29B | $3.79B | $-3.78B | $-5.04 |
| 2018-06-30 | $6.84B | $4.12B | $-168.80M | $-0.23 |
| 2017-06-30 | $7.65B | $4.62B | $-422.20M | $-0.66 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2026-06-30 | 62.89% | -10.42% | -19.13% | -0.98% |
| 2025-06-30 | 64.84% | -6.24% | -9.89% | 3.06% |
| 2024-06-30 | 64.39% | 1.46% | 2.23% | 5.77% |
| 2023-06-30 | 63.87% | 9.15% | 12.71% | 4.36% |
| 2022-06-30 | 63.52% | 4.89% | 7.76% | 1.53% |
| 2021-06-30 | 59.79% | -4.35% | -6.57% | -0.28% |
| 2020-06-30 | 57.79% | -21.34% | -31.18% | -7.52% |
| 2019-06-30 | 60.26% | -60.18% | -82.38% | -30.49% |
| 2018-06-30 | 60.27% | -2.47% | -1.91% | -0.77% |
| 2017-06-30 | 60.42% | -5.52% | -4.53% | -1.32% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2026-06-30 | $176.10M | $3.03B |
| 2025-06-30 | $257.10M | $3.96B |
| 2024-06-30 | $300.80M | $3.84B |
| 2023-06-30 | $246.90M | $4.18B |
| 2022-06-30 | $233.30M | $4.41B |
| 2021-06-30 | $253.50M | $5.40B |
| 2020-06-30 | $308.30M | $7.89B |
| 2019-06-30 | $340.40M | $7.47B |
| 2018-06-30 | $331.60M | $7.31B |
| 2017-06-30 | $535.40M | $6.93B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2026-06-30 | $348.20M | $46.30M |
| 2025-06-30 | $277.60M | $50.00M |
| 2024-06-30 | $369.40M | $88.80M |
| 2023-06-30 | $402.90M | $135.90M |
| 2022-06-30 | $552.50M | $195.50M |
| 2021-06-30 | $144.80M | $29.90M |
| 2020-06-30 | $-318.30M | $29.80M |
| 2019-06-30 | $213.00M | $14.80M |
| 2018-06-30 | $-32.70M | $30.60M |
| 2017-06-30 | $325.20M | $24.60M |
Dividend history
- Most recent payment
- 2020-02-14
| Payment date | Dividend per share |
|---|
| 2020-02-14 | $0.13 |
| 2019-11-15 | $0.13 |
| 2019-09-06 | $0.13 |
| 2019-06-05 | $0.13 |
| 2019-02-27 | $0.13 |
| 2018-11-29 | $0.13 |
| 2018-08-30 | $0.13 |
| 2018-05-30 | $0.13 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-04
- Consensus EPS estimate
- $0.12
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-08-19 | Jun/2026 | - |
| 2026-05-05 | - | - |
| 2026-02-05 | - | - |
| 2025-11-05 | - | - |
| 2025-08-20 | - | - |
| 2025-05-06 | - | - |
| 2025-05-05 | - | - |
| 2025-02-10 | - | - |
Filings and sources
- Company website
- coty.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Procter & Gamble Co (PG) · Colgate-Palmolive Co (CL) · Estee Lauder Companies Inc (EL) · Kimberly-Clark Corp (KMB) · Church & Dwight Co Inc (CHD) · Clorox Co (CLX) · Constellation Brands, Inc. (STZ) · Molson Coors Beverage Co (TAP)
All Consumer Defensive companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades